Pharnext Executes A Financing Agreement With Néovacs For Eur 20.7 Million Net To Further Develop Pxt3003 For Charcot-Marie-Tooth Disease Type 1A
Round Type
Debt Financing
ParisBiotechnologyTherapeuticsPharmaceuticalBiopharmaDescription
PARIS, FRANCE / October 3, 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, today announces the signature of a financing agreement, by which Néovacs (FR00140077X1 - ALNEV), a French biotech company focused on therapeutic vaccines targeting the treatment of autoimmune diseases and investment support of promising biotech and medtech companies, undertakes to subscribe to simple obligations to be issued by Pharnext in an issuance program spanning until July 2023, for a total nominal amount of EUR 21,093,800 (EUR 20.7 million net) (the "Bonds").
Quick answer
Pharnext raised an undisclosed amount in a Debt Financing round, dated October 3, 2022. Pharnext is based in Paris, Ile-de-France, France.
- How much did Pharnext raise?
- Pharnext raised an undisclosed amount in a Debt Financing round on October 3, 2022.
- What does Pharnext do?
- Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments.
- Where is Pharnext based and how big is it?
- Pharnext is based in Paris, Ile-de-France, France.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Pharnext that raised within 45 days of this round, from Fundz verified event records.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
- NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
Who to call at Pharnext, and when
A new round usually means Pharnext is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pharnext raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pharnext, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pharnext. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pharnext raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Pharnext raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.